Octréotide - SANDOSTATINE L.P. 30 mg, poudre et solvant pour suspension injectable

Business Listing - December 25, 2019

Octréotide SANDOSTATINE L.P. 30 mg, poudre et solvant pour suspension injectable - H01CB02 NOVARTIS PHARMA - 61881699

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.